Option Care Health Is Maintained at Outperform by Barrington Research
Option Care Health Analyst Ratings
Barrington Research Maintains Outperform on Option Care Health, Raises Price Target to $33
Barrington Initiates Option Care Health(OPCH.US) With Buy Rating, Announces Target Price $33
Strong Financial Outlook and Growth Potential for Option Care Health: Analyst Recommends Buy Rating
Truist Financial Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $34
BofA Securities Maintains Option Care Health(OPCH.US) With Buy Rating, Cuts Target Price to $33
JMP Securities Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $30
Option Care Health Price Target Cut to $30.00/Share From $31.00 by JMP Securities
JMP Securities Maintains Option Care Health(OPCH.US) With Buy Rating, Cuts Target Price to $30
Option Care Health: Buy Rating Amid Growth Opportunities and Strategic Investments
UBS Initiates Option Care Health(OPCH.US) With Hold Rating, Announces Target Price $26
Critical Insights From Option Care Health Analyst Ratings: What You Need To Know
Option Care Health Initiated at Neutral by UBS
UBS Initiates Coverage On Option Care Health With Neutral Rating, Announces Price Target of $26
Option Care Health Analyst Ratings
Truist Financial Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $34
Option Care Health (OPCH) Gets a Buy From Truist Financial
Jefferies Maintains Option Care Health(OPCH.US) With Hold Rating, Maintains Target Price $26
Jefferies Remains a Hold on Option Care Health (OPCH)